XML 53 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Combinations
6 Months Ended
May 31, 2012
Business Combinations [Abstract]  
Business Combinations
Business Combinations

On October 26, 2011, we acquired all of the equity interests in Corticon Technologies, Inc. (Corticon), a privately held business enterprise software company based in Redwood City, California, for $23.0 million. Corticon is a business rules management system vendor that enables organizations to make better, faster decisions by automating business rules. The Corticon products became part of our Enterprise Business Solutions segment. The purpose of the acquisition was to expand the product offerings within the Enterprise Business Solutions segment. The acquisition was accounted for as a purchase, and accordingly, the results of operations of Corticon are included in our operating results from the date of acquisition. We paid the purchase price in cash from available funds.

The allocation of the purchase price is as follows (in thousands):
 
 
Preliminary Allocation
 
Final Allocation
 
Life
Accounts receivable
$
835

 
$
835

 
 
Property and equipment
112

 
112

 
 
Other assets
125

 
125

 
 
Acquired intangible assets
4,910

 
4,910

 
3 to 7 years
Deferred taxes
(1,814
)
 
4,033

 
 
Goodwill
24,842

 
19,427

 
 
Accounts payable and other liabilities
(2,471
)
 
(2,903
)
 
 
Deferred revenue
(3,639
)
 
(3,639
)
 
 
Net cash paid
$
22,900

 
$
22,900

 
 


We recorded the excess of the purchase price over the identified tangible and intangible assets as goodwill. We believe that the investment value of the future enhancement of our product and solution offerings created as a result of this acquisition has principally contributed to a purchase price that resulted in the recognition of $19.4 million of goodwill, which is not deductible for tax purposes. The allocation of the purchase price was completed in the second quarter of fiscal 2012, upon the finalization of our valuation of acquired deferred tax assets and liabilities.

We have not disclosed the amount of revenues and earnings of Corticon since acquisition, nor pro forma financial information, as those amounts are not significant to our condensed consolidated financial statements.